Á lódáil...
Novel combinations for the treatment of metastatic breast cancer
Anthracyclines and taxanes represent the mainstay of first-line cytotoxic therapy for metastatic breast cancer (MBC), but most patients eventually develop resistance to these agents. Consequently, alternative combinations for MBC therapy are the subject of much ongoing research. Capecitabine and ixa...
Na minha lista:
Príomhúdar: | |
---|---|
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Molecular Diversity Preservation International
2010
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3827587/ https://ncbi.nlm.nih.gov/pubmed/24281029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers2010001 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|